DK0605578T4 - Aerosolpræparater under tryk - Google Patents

Aerosolpræparater under tryk

Info

Publication number
DK0605578T4
DK0605578T4 DK92920611T DK92920611T DK0605578T4 DK 0605578 T4 DK0605578 T4 DK 0605578T4 DK 92920611 T DK92920611 T DK 92920611T DK 92920611 T DK92920611 T DK 92920611T DK 0605578 T4 DK0605578 T4 DK 0605578T4
Authority
DK
Denmark
Prior art keywords
under pressure
aerosol preparations
units
preparations under
liquefied hydrofluoroalkane
Prior art date
Application number
DK92920611T
Other languages
Danish (da)
English (en)
Other versions
DK0605578T3 (da
Inventor
Suresh Nagarbhai Mistry
Mark Gibson
Original Assignee
Fisons Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27450754&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0605578(T4) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GB919120396A external-priority patent/GB9120396D0/en
Priority claimed from GB919120675A external-priority patent/GB9120675D0/en
Priority claimed from GB919124661A external-priority patent/GB9124661D0/en
Priority claimed from GB929203212A external-priority patent/GB9203212D0/en
Application filed by Fisons Plc filed Critical Fisons Plc
Publication of DK0605578T3 publication Critical patent/DK0605578T3/da
Application granted granted Critical
Publication of DK0605578T4 publication Critical patent/DK0605578T4/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Otolaryngology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pulmonology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Colloid Chemistry (AREA)
  • Containers And Packaging Bodies Having A Special Means To Remove Contents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK92920611T 1991-09-25 1992-09-23 Aerosolpræparater under tryk DK0605578T4 (da)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB919120396A GB9120396D0 (en) 1991-09-25 1991-09-25 Formulations
GB919120675A GB9120675D0 (en) 1991-09-28 1991-09-28 Formulation
GB919124661A GB9124661D0 (en) 1991-11-19 1991-11-19 Formulations
GB929203212A GB9203212D0 (en) 1992-02-14 1992-02-14 Pharmaceutical formulations
PCT/GB1992/001749 WO1993005765A1 (en) 1991-09-25 1992-09-23 Pressurised aerosol compositions

Publications (2)

Publication Number Publication Date
DK0605578T3 DK0605578T3 (da) 1996-03-25
DK0605578T4 true DK0605578T4 (da) 2000-03-06

Family

ID=27450754

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92920611T DK0605578T4 (da) 1991-09-25 1992-09-23 Aerosolpræparater under tryk

Country Status (29)

Country Link
US (1) US6641800B1 (hu)
EP (2) EP0534731A1 (hu)
JP (1) JP3142136B2 (hu)
KR (1) KR100275426B1 (hu)
CN (1) CN1050285C (hu)
AT (1) ATE132739T1 (hu)
AU (1) AU654397B2 (hu)
BG (1) BG61752B1 (hu)
BR (1) BR9206549A (hu)
CA (1) CA2119932C (hu)
CZ (1) CZ282506B6 (hu)
DE (1) DE69207606T3 (hu)
DK (1) DK0605578T4 (hu)
ES (1) ES2082507T5 (hu)
FI (1) FI110407B (hu)
GR (2) GR3019098T3 (hu)
HK (1) HK1005564A1 (hu)
HU (2) HUT67480A (hu)
IL (1) IL103238A (hu)
MX (1) MX9205483A (hu)
MY (1) MY108309A (hu)
NO (1) NO307124B1 (hu)
NZ (1) NZ244439A (hu)
RO (1) RO114735B1 (hu)
RU (1) RU2122852C1 (hu)
SK (1) SK279456B6 (hu)
TW (1) TW216442B (hu)
UA (1) UA41873C2 (hu)
WO (1) WO1993005765A1 (hu)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7101534B1 (en) 1991-12-18 2006-09-05 3M Innovative Properties Company Suspension aerosol formulations
GB9214819D0 (en) * 1992-07-13 1992-08-26 Minnesota Mining & Mfg Valve assemblies
AU679511B2 (en) * 1993-03-17 1997-07-03 Minnesota Mining And Manufacturing Company Aerosol formulation containing an ester-, amide-, or mercaptoester-derived dispersing aid
JPH08507792A (ja) * 1993-03-17 1996-08-20 ミネソタ マイニング アンド マニュファクチャリング カンパニー ジオール−二酸から誘導される分散助剤を含むエーロゾル配合物
ES2183001T3 (es) 1995-06-27 2003-03-16 Boehringer Ingelheim Pharma Nuevo preparado medicamentoso estable para la produccion de aerosoles exentos de gas propulsor.
GB9616237D0 (en) 1996-08-01 1996-09-11 Norton Healthcare Ltd Aerosol formulations
US6039932A (en) * 1996-09-27 2000-03-21 3M Innovative Properties Company Medicinal inhalation aerosol formulations containing budesonide
US6126919A (en) * 1997-02-07 2000-10-03 3M Innovative Properties Company Biocompatible compounds for pharmaceutical drug delivery systems
US20010031244A1 (en) 1997-06-13 2001-10-18 Chiesi Farmaceutici S.P.A. Pharmaceutical aerosol composition
US6433040B1 (en) 1997-09-29 2002-08-13 Inhale Therapeutic Systems, Inc. Stabilized bioactive preparations and methods of use
US6565885B1 (en) 1997-09-29 2003-05-20 Inhale Therapeutic Systems, Inc. Methods of spray drying pharmaceutical compositions
US20060165606A1 (en) 1997-09-29 2006-07-27 Nektar Therapeutics Pulmonary delivery particles comprising water insoluble or crystalline active agents
US6309623B1 (en) 1997-09-29 2001-10-30 Inhale Therapeutic Systems, Inc. Stabilized preparations for use in metered dose inhalers
US6086376A (en) * 1998-01-30 2000-07-11 Rtp Pharma Inc. Dry aerosol suspension of phospholipid-stabilized drug microparticles in a hydrofluoroalkane propellant
US6136294C1 (en) * 1998-09-22 2002-09-24 Aeropharm Technology Inc Amino acid stabilized medical aerosol formulation
DZ2947A1 (fr) 1998-11-25 2004-03-15 Chiesi Farma Spa Inhalateur à compteur de dose sous pression.
IT1313553B1 (it) 1999-07-23 2002-09-09 Chiesi Farma Spa Formulazioni ottimizzate costituite da soluzioni di steroidi dasomministrare per inalazione.
US6540982B1 (en) * 2000-01-25 2003-04-01 Aeropharm Technology Incorporated Medical aerosol formulation
IT1317846B1 (it) 2000-02-22 2003-07-15 Chiesi Farma Spa Formulazioni contenenti un farmaco anticolinergico per il trattamentodella broncopneumopatia cronica ostruttiva.
WO2001078735A1 (en) * 2000-04-13 2001-10-25 Innovata Biomed Limited Medicaments for treating respiratory disorders comprising formoterol and fluticasone
US7871598B1 (en) 2000-05-10 2011-01-18 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
US8404217B2 (en) 2000-05-10 2013-03-26 Novartis Ag Formulation for pulmonary administration of antifungal agents, and associated methods of manufacture and use
WO2001085136A2 (en) 2000-05-10 2001-11-15 Alliance Pharmaceutical Corporation Phospholipid-based powders for drug delivery
CZ303833B6 (cs) 2000-05-22 2013-05-22 Chiesi Farmaceutici S.P.A. Aerosolový prostredek
DE60103527T2 (de) 2001-07-02 2005-06-16 Chiesi Farmaceutici S.P.A. Optimierte Tobramycin-Formulierung zur Aerosolbildung
GB0208742D0 (en) 2002-04-17 2002-05-29 Bradford Particle Design Ltd Particulate materials
MXPA04005865A (es) 2001-12-19 2004-09-13 Nektar Therapeutics Suministro de aminoglucosidos a los pulmones.
US7544177B2 (en) * 2002-01-24 2009-06-09 The Regents Of The University Of California Aerosol device to deliver bioactive agent
SE0200312D0 (sv) * 2002-02-01 2002-02-01 Astrazeneca Ab Novel composition
US7244742B2 (en) * 2002-08-17 2007-07-17 Boehringer Ingelheim Pharma Gmbh & Co Kg Pharmaceutical compositions for inhalation containing an anticholinergic, corticosteroid and betamimetic
GB0328630D0 (en) * 2003-12-10 2004-01-14 Medpharm Ltd Metered dose inhalation preparations
EP1595531A1 (en) 2004-05-13 2005-11-16 CHIESI FARMACEUTICI S.p.A. Stable pharmaceutical solution formulations for pressurized metered dose inhalers
WO2005089738A2 (en) * 2004-03-17 2005-09-29 Mpex Pharmaceuticals, Inc. Use and administration of bacterial efflux pump inhibitors
US7994225B2 (en) * 2004-03-17 2011-08-09 Rempex Pharmaceuticals, Inc. Bacterial efflux pump inhibitors for the treatment of ophthalmic and otic infections
US20070031343A1 (en) * 2005-08-04 2007-02-08 Bonfour Charles A Iii Flavored medicinal inhalant
FR2895260B1 (fr) * 2005-12-23 2009-02-20 Servier Lab Nouvelle composition pharmaceutique a base d'huile essentielle pour pulverisation nasale et/ou buccale
DE102006017320A1 (de) * 2006-04-11 2007-10-18 Boehringer Ingelheim Pharma Gmbh & Co. Kg Aerosolsuspensionsformulierungen mit TG 227 ea oder TG 134 a als Treibmittel
ES2691033T3 (es) 2007-02-11 2018-11-23 Map Pharmaceuticals Inc. Método de administración terapéutica de DHE para activar el alivio rápido de la migraña a la vez que se reduce al mínimo el perfil de los efectos secundarios
WO2008152398A2 (en) * 2007-06-14 2008-12-18 Cipla Limited Formulations for inhalation
GB0712454D0 (en) 2007-06-27 2007-08-08 Generics Uk Ltd Pharmaceutical compositions
EP2274039A2 (en) 2008-05-06 2011-01-19 Wilson-Cook Medical Inc. Apparatus and methods for delivering therapeutic agents
CN102238939B (zh) * 2008-11-04 2015-05-20 希普拉有限公司 药物气溶胶组合物
CA2747390C (en) 2008-12-23 2016-10-04 Wilson-Cook Medical Inc. Apparatus and methods for containing and delivering therapeutic agents
US8118777B2 (en) 2009-05-29 2012-02-21 Cook Medical Technologies Llc Systems and methods for delivering therapeutic agents
US9101744B2 (en) 2009-05-29 2015-08-11 Cook Medical Technologies Llc Systems and methods for delivering therapeutic agents
CN102416179B (zh) 2010-09-28 2014-05-07 益得生物科技股份有限公司 用于哮喘的吸入性复方组合物
US9867931B2 (en) 2013-10-02 2018-01-16 Cook Medical Technologies Llc Therapeutic agents for delivery using a catheter and pressure source
US11931227B2 (en) 2013-03-15 2024-03-19 Cook Medical Technologies Llc Bimodal treatment methods and compositions for gastrointestinal lesions with active bleeding
GB201402513D0 (en) * 2014-02-13 2014-04-02 Cardiff Scintigraphics Ltd Pressurised metered dose inhalers and method of manufacture
WO2016018892A1 (en) 2014-07-29 2016-02-04 3M Innovative Properties Company Method of preparing a pharmaceutical composition
JP7063806B2 (ja) * 2015-10-23 2022-05-09 ビーエーエスエフ ソシエタス・ヨーロピア 皮膚適用のための香料制御放出性配合物
US10702495B2 (en) 2017-02-20 2020-07-07 Nexien Biopharma, Inc. Method and compositions for treating dystrophies and myotonia
EP3750528A1 (en) 2019-06-11 2020-12-16 Nexien Biopharma, Inc. Compositions for treating dystrophies and myotonia

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US417295A (en) * 1889-12-17 Fabriken
AT274245B (de) 1967-05-17 1969-09-10 Verfahren zur Herstellung eines Spezialklebers für Verbandmaterialien
US4025635A (en) 1972-09-06 1977-05-24 Burroughs Wellcome Co. Cyclic sulphur compounds
CA1136547A (en) * 1979-03-08 1982-11-30 Song-Ling Lin Aerosol anesthetic compositions
EP0175671A1 (de) 1984-08-23 1986-03-26 Kuhlemann & Co. Pharmazeutische Zubereitung sowie Verfahren zum Darreichen dieser pharmazeutischen Zubereitung
AU597049B2 (en) * 1986-03-10 1990-05-24 Kurt Burghart Pharmaceutical preparation containing nifedipine
US4863720A (en) 1986-03-10 1989-09-05 Walter Burghart Pharmaceutical preparation and methods for its production
US4752466A (en) 1987-08-31 1988-06-21 Johnson & Johnson Products, Inc. Thrombin aerosol
US5225183A (en) 1988-12-06 1993-07-06 Riker Laboratories, Inc. Medicinal aerosol formulations
GB8828477D0 (en) * 1988-12-06 1989-01-05 Riker Laboratories Inc Medical aerosol formulations
GB8921222D0 (en) 1989-09-20 1989-11-08 Riker Laboratories Inc Medicinal aerosol formulations
IL95952A0 (en) 1989-10-19 1991-07-18 Sterling Drug Inc Aerosol composition for topical medicament
IE67185B1 (en) 1990-02-02 1996-03-06 Fisons Plc Propellant compositions
US6123924A (en) * 1991-09-25 2000-09-26 Fisons Plc Pressurized aerosol inhalation compositions
US5658549A (en) 1991-12-12 1997-08-19 Glaxo Group Limited Aerosol formulations containing propellant 134a and fluticasone propionate
US5874064A (en) * 1996-05-24 1999-02-23 Massachusetts Institute Of Technology Aerodynamically light particles for pulmonary drug delivery

Also Published As

Publication number Publication date
UA41873C2 (uk) 2001-10-15
KR100275426B1 (ko) 2001-03-02
FI941388A0 (fi) 1994-03-25
ES2082507T3 (es) 1996-03-16
NO941077D0 (no) 1994-03-24
CA2119932A1 (en) 1993-04-01
DE69207606T3 (de) 2000-03-16
BG98681A (bg) 1995-02-28
MX9205483A (es) 1993-05-01
TW216442B (en) 1993-11-21
HU9400853D0 (en) 1994-06-28
NO941077L (no) 1994-05-18
WO1993005765A1 (en) 1993-04-01
CN1071832A (zh) 1993-05-12
EP0534731A1 (en) 1993-03-31
HK1005564A1 (en) 1999-01-15
GR3019098T3 (en) 1996-05-31
CN1050285C (zh) 2000-03-15
DE69207606D1 (de) 1996-02-22
CA2119932C (en) 2002-05-21
RU2122852C1 (ru) 1998-12-10
DK0605578T3 (da) 1996-03-25
JPH07502262A (ja) 1995-03-09
CZ282506B6 (cs) 1997-07-16
HU210818A9 (en) 1995-08-28
US6641800B1 (en) 2003-11-04
ATE132739T1 (de) 1996-01-15
FI941388A (fi) 1994-03-25
SK34094A3 (en) 1994-11-09
AU654397B2 (en) 1994-11-03
NZ244439A (en) 1994-01-26
MY108309A (en) 1996-09-30
GR3032103T3 (en) 2000-03-31
ES2082507T5 (es) 1999-11-16
JP3142136B2 (ja) 2001-03-07
HUT67480A (en) 1995-04-28
BG61752B1 (bg) 1998-05-29
SK279456B6 (sk) 1998-11-04
BR9206549A (pt) 1995-10-17
EP0605578B1 (en) 1996-01-10
NO307124B1 (no) 2000-02-14
IL103238A0 (en) 1993-02-21
DE69207606T2 (de) 1996-06-27
EP0605578A1 (en) 1994-07-13
EP0605578B2 (en) 1999-09-22
AU2647192A (en) 1993-04-27
IL103238A (en) 1995-07-31
RO114735B1 (ro) 1999-07-30
CZ69594A3 (en) 1995-11-15
FI110407B (fi) 2003-01-31

Similar Documents

Publication Publication Date Title
DK0605578T3 (da) Aerosolpræparater under tryk
CA2155956A1 (en) Aerosol delivery apparatus
AU6633394A (en) A device for local drug delivery and methods for using the same
ZA988203B (en) Aerosol medication delivery apparatus and system.
EP0674528A4 (en) DRUG DELIVERY SYSTEM BASED ON CYCLODEXTRIN AND A POLYMER.
CA2156075A1 (en) Aerosol formulation containing a dispersing aid
AU629095B2 (en) Equine aerosol drug delivery method and apparatus
ATE196076T1 (de) Aerosol arzneiformulierungen
EP0660605A3 (en) Video signal storage and distribution apparatus and system.
EP0750494A4 (en) HYDROPHOBIC DRUG DELIVERY SYSTEMS
ZA926019B (en) Pharmaceutical spheroid formulation.
WO1997028104A3 (de) Puffersysteme zur stabilisierung pharmazeutischer zubereitungen
DE69005765D1 (de) Druckgasgefäss mit kontrollierter Gasabgabe.
AU8068294A (en) Gas pressurized liquid delivery system
GB9305120D0 (en) Neuropeptides and their use as insecticides
AU8064091A (en) Pharmaceutical preparation
AU1452492A (en) Optically active carboxylic acids and medicaments containing them
ES2064244A1 (es) Composiciones de aerosol presurizadas.
GR1001487B (el) Πεπιεσμένες συν?έσεις αεροζόλης.
ITBO910403A0 (it) Apparecchiatura per immettere una sostanza gassosa in pressione en- tro un contenitore e per sigillare il contenitore stesso.
CA2249637A1 (en) Uniform drug delivery therapy
IL124423A0 (en) Pharmaceutical composition comprising an active compound in a polymer
ATE99951T1 (de) Pharmazeutische zusammensetzungen mit gehalt an calcitonin zur intranasalen verabreichung und eine spray-einheit zur verabreichung derselben.